# NOURESS
> **NDA212535** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2019-12-13
## Drug
- **FDA Application Number:** NDA212535
- **Application type:** New Drug Application
- **Brand name:** NOURESS
- **Generic name:** CYSTEINE HYDROCHLORIDE
- **Active ingredients:** CYSTEINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2019-12-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212535)
---
*MORVS · CC0 1.0*